The notion that impairment can be assumed or not based solely on specific concentrations of THC or its metabolites in a driver’s blood or urine is plainly wrong.
There are several options provided by the US federal government that hemp and CBD businesses can take advantage of during these turbulent times.
I have observed that many people fail to “think properly” about how to handle financial downturns and find themselves thrashing in the dark, despite the fact that there are a number of simple and effective methods for managing cash flow that produce results.
As a service to our current clients and readers during these difficult times, we are offering a free 20-minute phone call to address your pressing issues – no strings attached.
For my talk, I compared and contrasted the hemp and CBD regulatory regimes in Europe and US. Although they parallel each other in some respects, particularly policy, they are fundamentally different in their approaches.
The FDA has yet to create a regulatory pathway for CBD. Does its most recent report to Congress herald a change?
Lawyers are bound by standards unique to any other profession. Absent a very select set of circumstances or exceptions, a lawyer may not reveal any information related to representing a client.
The 2020 Industrial Hemp Summit in Danville, VA was an enormous success. I enjoyed speaking on the “Regulatory Lab” panel.
For a mother traveling with her child who needs medical marijuana to prevent or mitigate constant seizures, it is understandable that she may attempt to travel with that life-changing medication.
Although the DOT Notice regarding drug testing purports to clarify the law with respect to a certain category of “safety-sensitive” employees, it really just muddies the water.